Editorial
doi: 10.1097/HJH.0b013e3280d9434e.
Aldosterone antagonist therapy in resistant hypertension
- PMID: 17351364
- DOI: 10.1097/HJH.0b013e3280d9434e
Item in Clipboard
Editorial
Aldosterone antagonist therapy in resistant hypertension
J Hypertens.
2007 Apr.
No abstract available
Comment on
-
Low-dose spironolactone in the management of resistant hypertension: a surveillance study.J Hypertens. 2007 Apr;25(4):891-4. doi: 10.1097/HJH.0b013e328014954d. J Hypertens. 2007. PMID: 17351384
Similar articles
-
Amiloride 10 mg is less effective than spironolactone 25 mg in patients with hypertension resistant to a multidrug regime including an angiotensin-blocking agent.J Hypertens. 2007 Dec;25(12):2515-6. doi: 10.1097/HJH.0b013e3282f254d9. J Hypertens. 2007. PMID: 17984678 No abstract available.
-
Spironolactone for the treatment of isolated systolic hypertension.Am J Hypertens. 2004 Mar;17(3):284. doi: 10.1016/j.amjhyper.2003.11.009. Am J Hypertens. 2004. PMID: 15001208 No abstract available.
-
More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension.Blood Press. 2008;17(3):132-3. doi: 10.1080/08037050802312418. Blood Press. 2008. PMID: 18665471 No abstract available.
-
Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?Clin Ther. 2007 Sep;29(9):1803-24. doi: 10.1016/j.clinthera.2007.09.019. Clin Ther. 2007. PMID: 18035185 Review.
-
Endocrine arterial hypertension: therapeutic approach in clinical practice.Minerva Endocrinol. 2008 Dec;33(4):297-312. Minerva Endocrinol. 2008. PMID: 18923367 Review.
Cited by
-
2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension.Clin Hypertens. 2019 Aug 1;25:20. doi: 10.1186/s40885-019-0124-x. eCollection 2019. Clin Hypertens. 2019. PMID: 31388453 Free PMC article.
-
Aldosterone synthase inhibition in hypertension.Curr Hypertens Rep. 2013 Oct;15(5):484-8. doi: 10.1007/s11906-013-0379-7. Curr Hypertens Rep. 2013. PMID: 23917810 Review.
-
Novel antihypertensive therapies: renal sympathetic nerve ablation and carotid baroreceptor stimulation.Curr Hypertens Rep. 2012 Dec;14(6):567-72. doi: 10.1007/s11906-012-0312-5. Curr Hypertens Rep. 2012. PMID: 23011743
-
Pathophysiology of resistant hypertension: the role of sympathetic nervous system.Int J Hypertens. 2011 Jan 20;2011:642416. doi: 10.4061/2011/642416. Int J Hypertens. 2011. PMID: 21331155 Free PMC article.
-
Is there a blood pressure lowering effect of MRAs in heart failure? An overview and meta-analysis.Heart Fail Rev. 2018 Jul;23(4):547-553. doi: 10.1007/s10741-018-9689-9. Heart Fail Rev. 2018. PMID: 29527640 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
